Helex
Founded 2021 · 35 employees on LinkedIn · 3 known investors
Helex is a biotech company whose team specializes in molecular biology, drug delivery, biomedical engineering, and nanotechnology research.
Investors · 3
Also in the syndicate · 1
Bluehill Capital
Funding
SEC filings, press & company announcements$3.5M disclosed across 1 of 2 rounds · 2025
- Undisclosed amountSeedNov 2025
pi Ventures (lead)
Source ↗ - $3.5Mseed roundOct 2025 · 3 sources
pi Ventures (lead), Bluehill Capital, SOSV
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 6
by search overlap
Helix12 shared keywordsHelix operates a precision health platform connecting patients, physicians, health systems, and life sciences organizations to genetic testing and genomic data. Its offerings include clinical genetic testing (Helix Diagnostics), population genomics (Helix Research Network), a clinico-genomic research database (GenoSphere), and cost-management tools for health plans.
Lexicon Pharmaceuticals12 shared keywords
Helix Biomedix11 shared keywordsHelix BioMedix is a publicly traded company (OTCMKTS: HXBM). The stock information page provides investor relations and transfer agent details but does not describe the company's products or business activities.
Exelixis9 shared keywordsExelixis is an oncology company that discovers and develops cancer treatments, including small molecule therapeutics and biotherapeutics such as antibody-drug conjugates, for patients across multiple tumor types. Its flagship commercial product is CABOMETYX (cabozantinib), and it operates through global development and commercialization partnerships.
Healx6 shared keywordsHealx uses artificial intelligence to redevelop, combine, and enhance known compounds to build a pipeline of therapies for rare diseases, with an expanding focus on oncology and preventing cancer recurrence. The company runs multiple drug discovery programmes in parallel, bringing candidate treatments from prediction through clinical trials.
Lexeotx6 shared keywordsLEXEO Therapeutics develops gene therapy candidates aimed at genetically mediated cardiovascular diseases and APOE4-associated Alzheimer's disease. The clinical-stage company builds on research from Weill Cornell Medicine and the University of California San Diego.
Companies competing with Helex for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Helex do?
- Helex is a biotech company whose team specializes in molecular biology, drug delivery, biomedical engineering, and nanotechnology research.
- Who are Helex's investors?
- Helex's investors include pi Ventures, SOSV.
- How much funding has Helex raised?
- Helex has disclosed $3.5M raised across 1 of its 2 known rounds.